Abstract:Objective: The objective of this study was to compare the outcomes of pharmacomechanical thrombolysis and thrombectomy (PCDT) plus catheter-directed thrombolysis (CDT) vs CDT alone for the treatment of acute iliofemoral deep vein thrombosis (DVT) and summarize the clinical experience, safety outcomes, and short- and long-term efficacy.Methods: We performed a 4-year retrospective, case-control study. A total of 95 consecutive patients with acute symptomatic iliofemoral deep vein thrombosis (DVT) with a symptom duration of <= 7 days involving the iliac and/or common femoral veins underwent endovascular interventions. The patients were divided into two groups according to their clinical indications: PCDT plus CDT vs CDT alone. Statistical analyses were used to compare the clinical characteristics and outcomes between the two groups. Additionally, the patients were followed up for 3 to 36 months after treatment, and the proportions of post-thrombotic syndrome (PTS) and moderate to severe PTS were analyzed using the Kaplan-Meier survival method.Results: A total of 95 consecutive patients were analyzed in this retrospective study, of whom, 51 underwent CDT alone and 44 underwent PCDT plus CDT. Between the two groups, in terms of immediate-term efficacy and safety, significant differences were found in the catheter retention time (60.64 +/- 12.04 hours vs 19.42 +/- 4.04 hours; P < .001), dosages of urokinase required (5.82 +/- 0.81 million units vs 1.80 +/- 0.64 million units; P < .001), the detumescence rate at 24 hours postoperatively (48.46% +/- 8.62% vs 76.79% +/- 7.98%; P = .026), the descent velocity of D-dimer per day (2266.28 +/- 1358.26 mu g/L/D vs 3842.34 +/- 2048.02 mu g/L/D; P = .018), total hospitalization stay (6.2 +/- 1.40 days vs 3.8 +/- 0.70 days; P = .024), number of postoperative angiograms (2.4 +/- 0.80 vs 1.2 +/- 0.30; P = .042), and grade III venous patency (>95% lysis: 54.5% vs 68.6%; P = .047). Furthermore, during the follow-up period, significant differences were found in the incidence of PTS (Villalta scale >= 5 or a venous ulcer: 47.0% vs 27.7%; P = .037), and the incidence proportion of moderate to severe PTS at 12 months (15.7% vs 4.5%; P = .024) and 24 months (35.3% vs 11.4%; P = .016).Conclusions: Compared with CDT alone, in the iliofemoral DVT subgroup with a symptom duration of <= 7 days, PCDT plus CDT could significantly relieve early leg symptoms, shorten the hospitalization stay, reduce bleeding complications, promote long-term venous patency, and decrease the occurrence of PTS and the incidence proportion of moderate to severe PTS. Thus, the short- and long-term outcomes both support the superiority of PCDT plus CDT vs CDT in this subgroup.

Interventional Therapy for Upper Extremity Phlegmasia Cerulea Dolens in a Patient With Heparin-Induced Thrombocytopenia: A Case Report

Endovascular treatment of upper limb phlegmasia cerulea dolens in a hemodialysis patient

Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review

A case of upper extremity deep vein thrombosis with long-term patency using pharmaco-mechanical catheter-directed thrombolysis in the acute phase

Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report

When Anticoagulation Backfires - Heparin-Induced Thrombocytopenia and Acute Stent Thrombosis following Endovascular Therapy for Deep Vein Thrombosis: A Case Report

Staged Treatment of Phlegmasia Cerulea Dolens in a Patient with Iliac Vein Compression Syndrome and Deep Vein Thrombosis: A Case Report

Warfarin associated venous limb gangrene in cancer-related DVT (case report)

Acute right extremity deep vein thrombosis and left-sided inferior vena cava thrombosis treated by percutaneous mechanical thrombectomy (PMT) combined with catheter directed thrombolysis (CDT): A case report

Acute limb ischemia due to severe heparin-included thrombocytopenia with thrombosis during puerperium

Phlegmasia cerulea dolens in a patient treated with carboplatin

Intraoperative Bivalirudin Use in Patient Undergoing Femoral Endarterectomy with Heparin-Induced Thrombocytopenia: Case Report and Review of the Literature

Heparin-induced Thrombocytopenia in Renal Insufficiency Undergoing Dialysis and Percutaneous Coronary Intervention after Acute Myocardial Infarction: A Case Report.

Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia

Rescue From Permanent Kidney Injury in Acute Thrombosis of Both Renal Veins, the Inferior Vena Cava, and Both Iliofemoral Veins by Catheter-Based Thrombectomy

Efficacy of Therapeutic Plasma Exchange or Cangrelor as an Adjunctive Strategy to Facilitate Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia: A Systematic Review and Meta-Analysis

Feasibility of Anticoagulation Using Low Molecular-Weight Heparin During Catheter-Directed Thrombolysis for Lower Extremity Deep Venous Thrombosis

Catheter-Directed Interventions for the Treatment of Lower Extremity Deep Vein Thrombosis

Type II Heparin-Induced Thrombocytopenia Manifesting As Cardiac Arrest Following Intravenous Heparin Bolus During an Elective Procedure: A Case Report and Literature Review

Catheter-Directed Thrombolysis of Acute Entire Limb Deep Vein Thrombosis From below the Knee Access: A Retrospective Analysis of a Single-Center Experience.

Comparative Outcomes of Catheter-Directed Thrombolysis Versus AngioJet Pharmacomechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis.